PROVECTUS BIOPHARMACEUTICALS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $2.85K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $1.68K, a 45.65% increase year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2020-09-30 was $2.81K, a 60.74% increase year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $1.15K, a 87.17% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2019 was $11.54K, a 85.58% decline from fiscal 2018.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2018 was $80.00K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2016 was $20.16K, a 90.06% decline from fiscal 2015.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2015 was $202.81K, a 51.51% decline from fiscal 2014.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-09-30 | $2.85K 10-Q · filed 2024-11-12 | |
| 2021-06-30 | $1.68K 10-Q · filed 2021-11-10 | |
| 2020-09-30 | $2.81K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.15K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $11.54K 10-K · filed 2020-03-05 | |
| 2019-09-30 | $1.75K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $8.96K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $80.00K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $20.16K 10-K · filed 2018-03-23 | |
| 2015-12-31 | $37.38K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $202.81K 10-K · filed 2017-03-31 |
| 2015-09-30 | $38.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2015-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | |
| 2015-03-31 | $64.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $418.25K 10-K · filed 2017-03-31 | |
| 2013-12-31 | $526.00K 10-K · filed 2016-03-30 | |
| 2012-12-31 | $456.50K 10-K · filed 2015-03-12 | |
| 2006-12-31 | $650.64K 10-K · filed 2013-03-14 | |
| 2003-12-31 | $281.50K 10-K · filed 2013-03-14 |